Transaction in Own Shares - Replacement

Summary by AI BETAClose X

Templeton Emerging Markets Investment Trust PLC announced a correction to a previous RNS, clarifying that on September 28, 2026, it purchased 200,000 ordinary shares for cancellation at 329.25 pence per share. Following this transaction, the company's total voting rights stand at 905,791,789, with 60,000,000 shares held in treasury, which will only be reissued above the prevailing net asset value per share. This updated figure of 905,791,789 is to be used by shareholders for FCA Disclosure Guidance and Transparency Rules calculations.

Disclaimer*

Templeton Emerging Markets IT PLC
29 September 2026
 

Stock Exchange Announcement

Templeton Emerging Markets Investment Trust PLC ("the Company")

Transaction in Own Shares

Legal Entity Identifier 5493002NMTB70RZBXO96

 

This announcement replaces announcement under RNS 6389W released at 0450 hours on Monday 28 September 2026, the number of shares purchased was 200,000 and not 20,000 as advised.

 

 

The Company announces that, on 28 September 2026, it purchased for cancellation 200,000 Ordinary shares of 5 pence each in the Company ("Shares") at a price of 329.25 pence per Share.

 

Following this transaction, the Company's share capital consists of 905,791,789 Shares in issue and 60,000,000 Shares held in Treasury. Therefore, the total number of voting rights in the Company is 905,791,789. In order to protect the interests of existing shareholders, shares held in treasury will only be reissued at a price above the prevailing NAV per share at the time of reissue.

 

This figure (905,791,789) may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

For further information please e-mail temitcosec@franklintempleton.com.

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings